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INTRODUCTION
Enterococcus spp. represent important human 
and veterinary pathogens/opportunists and 
a significant burden for healthcare systems 
worldwide. Although enterococci are commen-
sal organisms in the gut of most animals and 
common in environments contaminated by 
human and animal faeces, they have emerged 
as nosocomial and community-acquired patho-
gens for their ability to develop high-level resis-
tance to antimicrobials (Werner et al., 2013). It 
is well known that the administration of anti-
microbials in humans and animal for the treat-
ment and control of infections, and in animals 
also as growth promoters can select resistant 
strains (Phillips et al., 2004). One example is the 
possible connection in Europe between the use 
of avoparcin in poultry and swine industries 
as feed additive, and the occurrence of vanco-
mycin-resistant enterococci in the intestine of 
animals and human consumers (Sundsjord et 
al., 2001). The antibiotic-resistant enterococci 
that enter the intestinal tract might colonize 
the host or just transfer their resistance genes 
by conjugation to resident bacteria (Leclercq 
et al., 1989; Schwarz et al., 2001), including 
pathogens, during their passage through the 
gut (Descheemaeker et al., 1999). For example, 
enterococci seem to be an important source of 
resistance genes (i.e. vanA) for Listeria spp. (Le-
clercq et al., 1989; de Niederhausern et al., 2004) 
and Staphylococcus aureus (Noble et al., 1992; 
de Niederhausern et al., 2011). In addition to 
antibiotic resistance, enterococci may exhibit 
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We investigated presence and prevalence of antibiotic-resistances and other biological characters in enterococci 
isolated from faeces of healthy dogs and cats because these microorganisms represent important human and 
veterinary pathogens/opportunists, and a significant burden for healthcare systems. In all samples (n=115) we 
detected enterococci, with a predominance of Enterococcus faecium (42; 36.5%) and Enterococcus faecalis (36; 
31.3%) species, endowed with virulence traits and multidrug-resistance. The two predominant resistance patterns 
(erythromycin, tetracycline) were examined by polymerase chain reaction for tet and erm genes. Only tetM for tet-
racycline, and ermA and ermB for erythromycin were detected. PCR for gelatinase gene (gelE) was positive in 62.6% 
of isolates, but only 26.1% produce gelatinase suggesting the existence of silent genes. efaAfs and efaAfm genes 
were found in E. faecalis and E. faecium respectively. 89.6% of isolates produced bacteriocin-like substances with a 
prevailing action against Listeria genus and, among these, 33.9% were positive for the bacteriocin structural genes 
entA, entL50 or entP. According to our study, pet animals can be considered a reservoir of potentially pathogenic 
enterococci and we cannot exclude that those microorganisms may be responsible for opportunistic infections in 
high-risk pet owners.
KEY WORDS: Antibiotic-resistances, Bacteriocin-like substances, Enterococci, Pets, Virulence factors.
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biological characteristics like gelatinase and 
bacteriocin/cytolysin that are considered com-
ponents of virulence (Eaton and Gasson, 2001; 
Jahan et al., 2013). Furthermore, the strains 
that produce bacteriocins or bacteriocin-like 
substances have advantages in the competition 
for ecological niche colonization as antibacte-
rial activity is assumed to be important in the 
regulation of population dynamics in bacterial 
ecosystems (Kalmokoff et al., 1999). As many 
biological characteristics contributing to viru-
lence in enterococci are frequently associated 
with pheromone-responsive conjugative plas-
mids (Laverde Gomez et al., 2011), their spread 
can become extremely fast, in particular where 
the density of bacteria and the variety of spe-
cies are high as in the gut of mammalians.
Many epidemiological studies on antimicrobial 
resistance have been conducted to better define 
the links between farm animals and humans. 
Previously most attention focused on farm an-
imals, but more recently research has begun to 
investigate whether companion animals play a 
role as a reservoir of resistant organisms giv-
en the close physical contact between house-
hold pets and their owners (Guardabassi et al., 
2004; Gulhan et al., 2006). Since the expression 
of all the above biological traits could justify 
an increased pathogenicity in enterococci and 
considering that companion animals are a po-
tentially important reservoir of these microor-
ganisms, the aim of the present investigation 
was to study the antimicrobial resistances, 
production of bacteriocin-like substances and 
virulence factors in enterococci isolated from 
faeces of healthy dogs and cats.
MATERIALS AND METHODS
Isolation and identification of enterococci
Faeces were collected from 79 dogs and 36 cats, 
all healthy, during routine visits to local veter-
inarians. All pets were fed with commercial 
food, periodically vaccinated and treated for 
parasites. The animals varied in sex, race, diet, 
and age and were not exposed to antimicrobials 
(including all oral, injectable and topical antibi-
otics) for at least one year prior to sample col-
lection. This experiment was exempt from the 
institutional animal care and use committee 
because it did not involve direct contact with 
animals. Enterococci were isolated by streak-
ing with a 10 μL loop serially diluted faeces 
samples on Kennel Fecal (KF)-Streptococcus 
agar (Difco Laboratories, Detroit, MI, USA). 
Plates were aerobically incubated for 48 h at 
37°C. For each sample, a red colony with the 
typical enterococcal morphology was random-
ly selected and presumptively identified to the 
genus level by Gram staining, catalase test and 
bile-esculin hydrolysis. All presumptive entero-
cocci were identified by biochemical character-
istics using Api 20 Strep system (bioMérieux, 
Marcy l’Etoile, France). Species identification 
was confirmed by PCR (Dutka-Malen et al., 
1995; Knijff et al., 2001).
Antimicrobial susceptibility testing
The minimal inhibitory concentrations (MICs) 
of enterococci were determined by agar di-
lution method according to the European 
Committee on Antimicrobial Susceptibility 
Testing (EUCAST 2011) guidelines using the 
EUCAST clinical breakpoints, when available, 
and in the other cases the breakpoints derived 
from CLSI (2011). The following antibacteri-
al agents were tested: penicillin, ampicillin, 
amoxicillin, piperacillin, streptomycin, gen-
tamicin, chloramphenicol, imipenem, tetracy-
cline, erythromycin, lincomycin, rifampicin, 
nitrofurantoin, ciprofloxacin, teicoplanin, 
vancomycin, tigecycline. For each antimicro-
bial a twofold dilution was performed to ob-
tain final concentrations from 0.5 to 256 μg 
mL-1; only streptomycin concentrations were 8 
to 2048 μg mL-1. All compounds were obtained 
from Sigma-Aldrich (St. Louis, MO, USA). E. 
faecalis ATCC 29212 was used as quality con-
trol reference strain. The isolates resistant to 
two or more classes of antimicrobials were 
considered multiresistant. 
Hemolysis, gelatinase and casein hydrolysis 
assays
Enterococci were cultured in Tryptic Soy broth 
(TSB, Oxoid, Italy) at 37°C for 24 h and spotted 
onto Blood Agar Base (Oxoid) containing 5% 
of defibrinated horse blood (Oxoid). After over-
night incubation at 37°C, the hemolytic activity 
was determined by the appearance of a clear 
zone of hemolysis (b-hemolysis), a partial and 
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greening hemolysis zone (α-hemolysis), or no 
activity (γ-hemolysis) around the spots.
Gelatinase production was evaluated using 
Todd-Hewitt agar plates containing gelatin (3% 
w/v) by spotting the plates with 10 µL of each 
suspension. After overnight incubation at 37°C, 
all the spots surrounded by an opaque halo 
were considered positive.
Casein hydrolysis was tested on Tryptic Soy agar 
(TSA, Oxoid) containing 3% (w/v) skimmed 
milk, by spotting the plates with 10 µL of each 
suspension followed by incubation at 37°C for 
24 h. The presence of a transparent zone around 
the spots indicated caseinase activity.
Bacteriocin-like substance production assay
All isolates were screened for bacteriocin-like 
substance production by the deferred antago-
nism method (Kekessy and Piguet, 1970). The 
following strains were used as indicators: Liste-
ria monocytogenes (NCTC 05105, NCTC 10888, 
NCTC 10890), Listeria innocua (ATCC BAA-680, 
ATCC 33090, NCTC 11288), Enterococcus faeca-
lis ATCC 29212, Lactobacillus acidophilus ATCC 
13651, Staphylococcus aureus ATCC 6538, 
Escherichia coli ATCC 25922. To eliminate in-
hibition due to hydrogen peroxide production, 
a first incubation was performed anaerobically. 
Antimicrobial activity was quantified by a clear 
zone of inhibition in the indicator lawn around 
the spot of the producer.
PCR detection of bacteriocin, virulence and 
antibiotic resistance determinants
Total DNA of strains, isolated by the rapid al-
kaline lysis method (Dutka-Malen et al., 1990), 
TABLE 1 - Polymerase chain reaction primers and their products.
Gene and 
primer
Nucleotide sequence (5’ to 3’) Product 
size (bp)
Ta (°C) References
gelE TE9: ACCCCGTATCATTGGTTT TE10: 
ACGCATTGCTTTTCCATC 
419 47 Eaton and Gasson (2001)
efaAfs TE5: GACAGACCCTCACGAATA TE6: 
AGTTCATCATGCTGTAGTA
705 47 Eaton and Gasson (2001)
efaAfm TE37: AACAGATCCGCATGAATA TE38: 
CATTTCATCATCTGATAGTA
735 46 Eaton and Gasson (2001)
agg TE3: AAGAAAAAGAAGTAGACCAAC TE4: 
AAACGGCAAGACAAGTAAATA
1553 40 Eaton and Gasson (2001)
cylB TE15: ATTCCTACCTATGTTCTGTTA TE16: 
AATAAACTCTTCTTTTCCAAC
843 40 Eaton and Gasson (2001)
cylM TE13: CTGATGGAAAGAAGATAGTAT TE14: 
TGAGTTGGTCTGATTACATTT
742 40 Eaton and Gasson (2001)
cylA F: TAGCGAGTTATATCGTTCACTGTA R: 
CTCACCTCTTTGTATTTAAGCATG
1282 55 Semedo et al. (2003)
entA F: GGTACCACTCATAGTGGAAA R: 
CCCTGGAATTGCTCCACCTAA
138 58 Aymeric et al. (1996)
ent L50 F: ATGGGAGCAATCGCAAAATTA R: 
TAGCCATTTTTCAATTTGATC
274 56 Cintas et al. (1998)
ent P F: GCTACGCGTTCATATGGTAAT R: 
TCCTGCAATATTCTCTTTAGC
87 56 Cintas et al. (1997)
erm A 5’-AAG CGG TAA ACC CCT CTG A-3’ 
5’-TTC GCA AAT CCC TTC TCA AC-3’
190 54 Strommenger et al. (2003)
erm C 5’-AAT CGT CAA TTC CTG CAT GT-3’ 
5’- TAA TCG TGG AAT ACG GGT TTG-3
299 54 Strommenger et al. (2003)
erm B 5’-CTATCTGATTGTTGAAGAAGGATT-3’
5’-GTTTACTCTTGGTTTAGGATGAAA-3’
142 54 Strommenger et al. (2003)
tet K 5’-GTA GCG ACA ATA GGT AAT AGT-3’ 
5’-GTA GTG ACA ATA AAC CTC CTA-3’
360 54 Strommenger et al. (2003)
tet M 5’-AGT GGA GCG ATT ACA GAA-3’ 
5’-CAT ATG TCC TGG CGT GTC TA-3’
158 54 Strommenger et al. (2003)
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was subjected to PCR amplification to detect 
the presence of genes involved in the expres-
sion of cytolysin (cylA, cylB, cylM), aggregation 
substance (agg), gelatinase (gelE), enterococcal 
surface protein (esp), cell wall adhesins (efaAfs 
and efaAfm), using the primers described in Ta-
ble 1. PCR amplification was also performed 
to detect structural genes of enterocin A (Ay-
merich et al., 1996), enterocin P and enterocin 
L50 (Cintas et al., 1997, 1998), and the antibi-
otic resistance determinants of tetracycline 
(tetK and tetM) and erythromycin (ermA, ermB 
and ermC) (Strommenger et al., 2003) because 
those for tetracycline and erythromycin are the 
most frequent resistances observed in entero-
cocci isolated from dogs and cats (Poeta et al., 
2005, 2006; Ossiprandi et al., 2008; Jackson et 
al., 2009).
RESULTS 
Isolation and identification of bacterial strains
Enterococci were demonstrated and the pre-
liminary identification of the isolates to species 
level by biochemical tests was confirmed by 
PCR results in all 115 samples from dogs and 
cats. The most frequently isolated species were 
Enterococcus faecium (42; 36.5%) and Entero-
coccus faecalis (36; 31.3%), followed by Entero-
coccus casseliflavus (15; 13%), Enterococcus 
durans (12; 10.4%), Enterococcus gallinarum (6; 
5.2%), Enterococcus hirae (3; 2.6%), Enterococ-
cus avium (1; 0.9%). 
Antimicrobial susceptibility testing
All 115 isolates displayed antibiotic resistances. 
In particular, 32 strains (27.8%) showed from 
TABLE 2 - Distribution (%) of minimum inhibitory concentration among Enterococcus strains (n=115).
MIC (μg mL-1) Break
Point≤0.5 1 2 4 8 16 32 64 128 256 512 1024 2048
Penicillin (30.4%) 15.7% 25.2% 20.9% 5.2% 2.6% 7.8% 0 0 22.6% 0 >8
Ampicillin 
(56.5%)
5.2% 13% 10.4% 9.5% 5.2% 13% 20% 23.5% 0 0   >8
Amoxicillin 
(39.1%)
25.2% 30.4% 5.2%  0  0 39.1% 0 0 0 0 >8
Piperacillin 
(31.2%)
13% 17.4% 13% 22.6% 2.6% 0 7.8% 5.2% 7.8% 10.4% >8
Streptomycin 
(18.2%)
0 0 7.8% 7.8% 13% 2.6 % 50.4% 13% 5.2% >512
Gentamicin 
(40.8%)
2.6% 2.6% 0 5.2% 22.6% 0 13% 0 13% 13% 14.8% 0 13% >128
Chloramphe-
nicol (61.8%)
0 0 0 5.2% 33% 0 14.8% 35.7% 11.3% 0 >16
Imipenem 
(56.4%)
9.5% 15.7% 5.2% 13% 0 10.4% 2.6% 2.6% 1.7% 39.1% >8
Tetracycline 
(97.4%)
0 2.6% 0 0 0 2.6% 25.2% 23.5% 46.1% 0 >4
Erythromy-cin 
(81.7%)
5.2% 2.6% 2.6% 7.8% 2.6% 5.2% 35.6% 2.6% 23.5% 12.2% >4
Lincomycin (0) 64.3% 35.7% 0 0 0 0 0 0 0 0 ≥8
Rifampicin 
(60.8%)
13% 5.2% 20.9% 25.2% 7.8% 18.3% 5.2% 0 2.6% 1.7% ≥4
Nitrofuran-
toin (49.6%)
0 0 1.7% 2.6% 0 2.6% 5.2% 38.3% 38.3% 11.3% >64
Ciprofloxacin 
(7.8%)
63.5% 15.6% 13% 0 0 0 2.6% 0 0 5.2% ≥4
Teicoplanin (0) 100% 0 0 0 0 0 0 0 0 0 >2
Vancomycin (0) 5.2% 46% 48.7% 0 0 0 0 0 0 0 >4
Tigecycline (0) 100% 0 0 0 0 >0,5
The numbers in bold show the percentage of strains resistant to each of the antibiotics tested.
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2 to 4 antibiotic-resistances, 68 (59.1%) from 5 
to 9, and 15 (13%) more than 9. The highest 
percentage of resistance (Table 2) was observed 
for tetracycline (97.5%), erythromycin (81.7%), 
chloramphenicol (61.8%) and rifampicin 
(60.8%). Enterococci were also resistant to am-
picillin (56.5%), imipenem (56.4%), nitrofuran-
toin (49.6%), gentamicin (40.8%). A lower rate 
of resistance was found for amoxicillin, pipera-
cillin and penicillin (39,1%, 31,2% and 30.4%, 
respectively) and only 21 strains (18.2%), were 
resistant to streptomycin and 9 (7.8%) to cip-
rofloxacin. While the relatively low percentage 
of quinolone-resistant isolates is in agreement 
with the results by Poeta et al., (2006) reporting 
8% of ciprofloxacin resistance, the resistance 
to high level of aminoglycosides (gentamicin, 
streptomycin) was detected in our isolates with 
a frequency higher than enterococci from pets 
in the EU studies of Poeta et al., (2006) and 
Damborg et al., (2008). 
At last all enterococci were susceptible to lin-
comycin, teicoplanin and tigecycline, and with 
the exception of E. casseliflavus and E. galli-
narum species that showed a characteristic in-
trinsic resistance, they were also susceptible to 
vancomycin. This result is in agreement with 
the studies on healthy and sick pets (dogs and 
cats) reported from Portugal (Rodrigues et al., 
2002; Delgado et al., 2007), Italy (Ossiprandi 
et al., 2008), the USA (Jackson et al., 2009), 
Spain (Lopez et al., 2013), Japan (Kataoka et 
al., 2013), and Korea (Chun et al., 2014). In 
our study, erythromycin and tetracycline resis-
tances were observed more frequently than the 
other antimicrobials and similar results were 
reported by Poeta et al. (2005, 2006), Ossip-
randi et al. (2008) and Jackson et al. (2009). 
As tetracycline and erythromycin are used 
for the treatment of a variety of infections in 
dogs and cats (urinary tract infections, peri-
odontitis, upper respiratory tract infections, 
conjunctiva) (Guardabassi et al., 2004; Escher 
et al., 2012), their use could be the cause of a 
selective pressure for the resistance phenotype 
(Jackson et al., 2009). Figure 1a shows the two 
predominant patterns of resistance (erythro-
mycin and tetracycline) examined by PCR for 
the presence of genes encoding antibiotic re-
sistance. Of the two types of tet genes inves-
tigated (tetK and tetM) only tetM have been 
identified. Of the three types of erm genes in-
vestigated (ermA, ermB and ermC) only ermA 
and ermB have been detected and ermB gene 
was the most represented. This result is in 
agreement with studies of enterococci from 
animal and human origin (Jensen et al., 1999; 
Schmitz et al., 2000; Mlynarczyk et al., 2010). 
The finding that a significant rate of tetracy-
cline resistant isolates shows co-resistance to 
erythromycin suggests that the selection of 
tetracycline resistant genotypes may provide a 
suitable molecular basis for the further selec-
tion of multiple resistances (Huys et al., 2004). 
Hemolysis, gelatinase, casein hydrolysis assays 
and PCR detection of virulence factor genes
b-hemolytic activity was absent in all entero-
cocci, as also reported by Gulhan et al. (2006), 
while α-hemolysis was observed in 73 isolates 
FIGURE 1 a, b - Examples of detection of resistance 
(a) and virulence factor (b) genes in isolated entero-
cocci by PCR reactions.
R. Iseppi, P. Messi, I. Anacarso, M. Bondi, C. Sabia, C. Condò, S. de Niederhausern374
(63.5%) (Table 3). Despite the absence of b-he-
molysis, 15 enterococci (13%) gave positive re-
sults for the cytolysin production genes (cylA, 
cylB, cylM) (Table 4, Figure 1b). The lack of 
b-hemolytic activity may be explained by an 
incomplete hemolysin gene set, low levels or 
down-regulation of gene expression or an in-
active gene product (Eaton and Gasson, 2001). 
Nevertheless, the molecular screening of cyl 
genes is necessary in non-hemolytic strains to 
evaluate their potential pathogenicity, since 
environmental factors may be involved in the 
control of cytolysin expression (Semedo et al., 
2003). Similarly, many enterococci carrying the 
gel gene were unable to hydrolyze gelatin sug-
gesting either the existence of silent genes or 
the dependence of gel gene expression on en-
vironmental and culture conditions (Lopes et 
al., 2006; Gomes et al., 2008). Actually, thirty of 
the isolates (26,1%) produced gelatinase, while 
PCR analysis for the gelatinase gene gelE gave 
positive results for 72 enterococci (62.6%). In 
particular, gelE gene was present in all isolat-
ed species with the exception of E. gallinarum 
and E. hirae. This result is in agreement with 
studies that reported finding the gelE gene in 
Enterococcus species different from E. faecalis 
and E. faecium (Poeta et al., 2006; Brtkova et 
al., 2011).
Production of the adhesin-like E. faecalis and 
E. faecium endocarditis antigens (EfaAfs and 
EfaAfm respectively) is considered a potential 
virulence determinant. In our study, the efaAfs 
and efaAfm genes were only found in E. faecalis 
and E. faecium (33% and 50% of the isolates re-
spectively). However, Semedo et al. (2003) and 
Barbosa et al. (2010) obtained negative amplifi-
cations for the efaAfs in E. faecalis and found E. 
TABLE 3 - Hemolysis, gelatinase and casein hydrolysis producers (%) among the 115 isolated strains.
α-hemolysis
(%)
b-hemolysis
(%)
γ-hemolysis
(%)
Gelatinase
(%)
Casein hydrolysis
(%)
E. faecium (n=42) 27 (64.2) 0 15 (35.7) 3 (7.1) 36 (85,7)
E. faecalis (n=36) 21 (58.2) 0 15 (41.7) 15 (41.7) 36 (100)
E. casseliflavus (n =15) 6 (40) 0 9 (60) 9 (60) 9 (60)
E. durans (n=12) 9 (75) 0 3 (25) 3 (25) 12 (100)
E. gallinarum (n=6) 6 (100) 0 0 0 3 (50)
E. avium (n=3) 3 (100) 0 0 0 3 (100)
E. hirae (n=1) 1 (100) 0 0 0 1 (100)
Total (n=115) 73 (63.48) 0 42 (36.52) 30 (26.08) 100 (86.96)
TABLE 4 - Distribution of virulence genes (%) found in the 115 isolated strains.
cylA 
(%)
cylB
(%)
cylM
(%)
agg 
(%)
gelE
(%)
esp
(%)
efaAfs 
(%)
efaAfm 
(%)
ent A 
(%)
entP
(%)
entL50 
(%)
E. faecium 
(n=42)
0 0 3 
(7.1)
0 24 
(57.1)
0 0 21 
(50)
12 
(28.5)
12 
(28.5)
0
E. faecalis 
(n=36)
3 
(8.3)
3 
(8.3)
3 
(8.3)
0 30 
(80.3)
0 12 
(33.3)
0 3 
(8.3)
0 3 
(8.3)
E. casseliflavus 
(n=15)
0 3 
(20)
0 0 9 
(60)
0 0 0 0 6 
(40)
0
E. durans 
(n=12)
0 0 0 0 6 
(50)
0 0 0 0 0 0
E. gallinarum 
(n=6)
0 0 0 0 0 0 0 0 3 
(50)
0 0
E. avium 
(n=3)
0 0 0 0 3 
(100)
0 0 0 0 0 0
E. hirae 
(n=1)
0 0 0 0 0 0 0 0 0 0 0
Total 
(n=115)
3 
(2.6)
6 
(5.2)
6 
(5.2)
0 72 
(62.6)
0 12 
(10.4)
21 
(18.2)
18 
(15.6)
18 
(15.6)
3 
(2.6)
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faecalis and other species isolated from differ-
ent samples with efaAfm. 
Aggregation substance (Agg) is a pheromone 
inducible surface protein that promotes mating 
aggregate formation during bacterial conjuga-
tion (Clewell, 1993). The enterococci agg posi-
tive may act as a source for horizontal transfer 
to other enterococci in the gut. This virulence 
factor could mediate the invasion and translo-
cation through intact colonic mucosa (Giridha-
ra Upadhyaya et al., 2010) and this may be the 
reason aggregation substance is more common 
among why blood and endocarditis isolates 
(Coque et al., 1995). In our strains, the gene for 
aggregation substance was not found, a reas-
suring result that suggests a reduced capability 
of the strains to transfer antibiotic resistance 
and virulence traits by mating.
Bacteriocin-like substances evaluation and PCR 
amplification of enterocin genes
One hundred and three of the 115 enterococci 
(89.6%), showed antibacterial activity against 
at least two indicators (Table 5). The prevail-
ing type of antagonism (75 producers equal 
to 77.1%), was directed against Listeria genus 
while L. acidophilus ATCC 13651 and S. aureus 
ATCC 6538 were inhibited respectively by 21 
(18.3%) and 9 (5.2%) strains. Conversely, E. coli 
ATCC 25922 was not inhibited. The antibacte-
rial activity was not significantly related to the 
isolated species even if E. faecalis exhibited the 
best inhibitory action. For bacteriocin genes 
tested (entA, entL50 and entP) (Table 4), 39 iso-
lates (33.9%) gave positive results. Enterocin A 
gene was found in 12 E. faecium (28.6%), 3 E. 
faecalis (8.3%) and 3 E. gallinarum (50%), en-
terocin L50 gene in 3 E. faecalis (8.3%), entero-
cin P gene in 12 E. faecium (28.6%) and 6 E. 
casseliflavus strains (40%). The gap detected in 
our study between the antibacterial activity and 
the occurrence of bacteriocin genes suggests 
that other types of bacteriocins or other inhibi-
tory substances may have affected the outcome. 
Our results are in agreement with Brandão et 
al. (2010) studies on enterococci in which the 
gene encoding EntP (entP) was the most repre-
sented in all tested ecosystems (humans, pets 
and wild animals) and the structural genes of 
EntA (entA) and EntL50 (entL50A and entL50B) 
were the next most frequently detected. The 
results related to the bacteriocin-like substanc-
es production and to the enterocin genes also 
show no important differences compared to 
those obtained from enterococci isolated in dif-
ferent environmental niches (Sabia et al., 2008). 
Actually there is no preferential ecological en-
vironment for the isolation of bacteriocin-pro-
ducing enterococci. This fact may be explained 
by the capability of enterococci to acquire and 
exchange genetic information by conjugation.
DISCUSSION
This work investigated antibiotic resistanc-
es and virulence traits, and the production of 
bacteriocin-like substances in enterococci iso-
lated from faeces of healthy dogs and cats. No 
important differences between strains isolated 
from the two types of companion animals were 
observed, and we collected and processed our 
data considering dogs and cats a unique reser-
voir of potentially pathogenic enterococci. In 
all samples we confirmed the presence of en-
terococci, with the predominance of E. faecium 
and E. faecalis, species endowed with multi-
drug resistance and virulence traits. Our results 
are in agreement with other authors (Rodrigues 
et al., 2002; Poeta et al., 2006; Ossiprandi et al., 
TABLE 5 - Bacteriocin-like substance producers (%) 
among the 115 isolated enterococci.
Indicators % BLS producers - + ++
Listeria monocytogenes 
NCTC 05105
38.5% 54% 7.5%
Listeria monocytogenes 
NCTC 10888
36% 61.5% 2.5%
Listeria monocytogenes 
NCTC 10890
69% 18% 13%
Listeria innocua 
ATCC BAA-680
36% 61.5% 2.5%
Listeria innocua NCTC 11288 79.5% 20.5% 0%
Listeria innocua ATCC 33090 90% 7.5% 2.5%
Enterococcus faecalis 
ATCC 29212
28% 56% 16%
Lactobacillus acidophilus 
ATCC 13651
82% 18% 0%
Staphylococcus aureus 
ATCC 6538
92% 8% 0%
Escherichia coli ATCC 25922 100% 0% 0%
-, no zone of inhibition; +, 5 mm <zone <10 mm; ++, 10 mm<zone<15 
mm.
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2008; Jackson et al., 2009) and confirm that E. 
faecium and E. faecalis are the most frequently 
isolated species from faeces of dogs and cats. 
Multi-resistant bacteria colonizing the intes-
tinal tract of healthy pets can reach a human 
host and exchange their resistance genes with 
bacteria resident in the human host; these bac-
teria are a cause of concern especially when 
the microorganisms carry resistance genes of 
clinical relevance and if associated with trans-
ferable genetic elements (Guardabassi et al., 
2004). PFGE data in a recent work by Chang 
et al. (2014) strongly indicated the possibility 
for cross-transmission of antibiotic-resistant 
Enterococcus clones among veterinary hospi-
tal-associated environments, such as dog pa-
tients, their owners, veterinary staff, and hospi-
tal environments.
In agreement with previous studies (Poeta et 
al., 2005, 2006; Ossiprandi et al., 2008; Jack-
son et al., 2009), erythromycin and tetracy-
cline are the two predominant patterns of re-
sistance observed in our isolates. This result is 
confirmed by the presence of tetM, ermA and 
ermB genes the most common genes encoding 
tetracycline and erythromycin resistance in 
enterococci (Jensen et al., 1999; Schmitz et al., 
2000; Mlynarczyk et al., 2010). The co-localiza-
tion on Tn1545 of tetracycline and erythromy-
cin resistances (ermB and tetM) has previously 
been reported in these bacteria (De Leener et 
al., 2004). Consequently, acquired resistance 
to tetracycline was frequently found in en-
terococci carrying the ermB gene (Cauwerts et 
al., 2007). The use of tetracyclines may thus 
co-select for resistance to macrolides, which 
may be important as an alternative therapy for 
enterococcal infections (Cauwerts et al., 2007). 
In a way it is comforting to know that no resis-
tance was observed against vancomycin, a gly-
copeptide considered to be the last resort drug 
in the treatment of enterococcal infections. 
Some authors (Lopez et al., 2013) claim the se-
lective pressure for maintenance of VRE with 
acquired mechanisms is less strong more than 
one decade after the avoparcin ban on animal 
growth promotion in the EU. This fact could 
justify the absence of vancomycin resistance 
among our isolates. 
The other biological traits (hemolytic, gelati-
nase and caseinase activities), in addition to 
the ability to produce bacteriocin-like sub-
stances, and the presence of virulence genes 
(gelE, efaAfm, efaAfs, cytolysin and enterocin 
genes), may emphasize the pathogenicity of 
the isolates. In some cases, our strains pos-
sessed silent virulence genes also, and it is now 
known that environmental signals may play a 
role in gene expression, influencing the switch 
to pathogenicity. Nevertheless, none of the de-
tected biological characters should be consid-
ered a definitive marker of pathogenicity. All 
of them could contribute to the virulence po-
tential of enterococci, either for the presence of 
additional virulence factors or for a decrease in 
the host of the immunity response (Marra et al., 
2007). In conclusion, from our results, pets can 
be considered a reservoir of potentially patho-
genic enterococci endowed with antimicrobial 
resistances and virulence factors. Therefore we 
cannot exclude the possibility that enterococci 
isolated from dogs and cats may be responsible 
for opportunistic infections in humans, partic-
ularly among high-risk owners.
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